Evidence map›Paper›PMID 24279416›Full record

ArticleCNS neuroscience & therapeutics2014

Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population.

Jian Qu, Ying Zhang, Zhi-Quan Yang, Xiao-Yuan Mao, Bo-Ting Zhou, Ji-Ye Yin, Hui He, Xiang-Ping Li, Hong-Yu Long, Nan Lv and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Pharmacogenomics in epilepsy.Neuroscience letters · 2018
    Review
  5. [Research advances in hereditary epilepsy and precision drug therapy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2017
    Review
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Jian QuInstitute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University Xiangya School of Medicine, Changsha, China.
Ying Zhang
Zhi-Quan Yang
Xiao-Yuan Mao
Bo-Ting Zhou
Ji-Ye Yin
Hui He
Xiang-Ping Li
Hong-Yu Long
Nan Lv
Xiao-Jing Xu
Bo Xiao
Yu Zhang
Qiang Tang
Dong-Li Hu
Hong-Hao Zhou
Zhao-Qian Liu
Central South University · CNHuaihua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe causes of genetic generalized epilepsies (GGEs) are still uncertain now. Some studies found that the human potassium channel, subfamily T, member 1 (KCNT1) is the candidate gene causing malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy which are all rare genetic generalized epilepsies. The aims of this study were going to evaluate the association between KCNT1 common variations and the susceptibility and drug resistance of genetic generalized epilepsies in Chinese population.

methodsThe allele-specific MALDI-TOF mass spectrometry method was used to assess 17 tagSNPs (tagged single-nucleotide polymorphisms) of KCNT1 in 284 healthy Chinese controls and 483 Chinese GGEs patients including 279 anti-epileptic drug-responsive patients and 204 drug-resistant patients.

resultsGenotype distributions of all the selected tagSNPs were consistent with Hardy-Weinberg equilibrium in GGEs and healthy controls. None of the all 17 tagSNPs alleles were found to be related with the susceptibility and drug resistance of genetic generalized epilepsies. The frequencies of haplotype 5 and haplotype 1 were significantly lower in GGEs than that in healthy controls (2% vs. 4%, OR = 0.47 [0.27-0.94], P = 0.03) and obviously higher in drug-resistant patients than that in drug-response patients (6% vs. 3%, OR = 2.56 [1.23-5.35], P = 0.01). However, after the correction of multiple comparisons with Bonferroni's method, we found that the above two haplotypes were not associated with the susceptibility and drug resistance in GGEs and healthy controls.

conclusionThis gene-wide tagging study revealed no association between KCNT1 17 common variations and susceptibility of GGEs or AEDs (anti-epileptic drugs) efficacy of genetic generalized epilepsies in Chinese population.

Indexed as

AdolescentAdultAnticonvulsantsChildChinaDrug ResistanceEpilepsy, GeneralizedFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleNerve Tissue ProteinsPolymorphism, Single NucleotidePotassium ChannelsPotassium Channels, Sodium-ActivatedAnticonvulsantsKCNT1 protein, humanNerve Tissue ProteinsPotassium ChannelsPotassium Channels, Sodium-ActivatedDrug resistanceEfficacyGenetic generalized epilepsiesGenetic polymorphismKCNT1Susceptibility

Identifiers

PMID24279416
PMCPMC6493076
OpenAlexW1965272472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.